The 2012 Annual Meeting of Stockholders of ImmuCell Corporation (the Company) was held at the Company's office at 56 Evergreen Drive, Portland, Maine 04103 on Thursday, June 14, 2012, at 8:30 a.m. Eastern Daylight Time, for the following purposes:

1. To elect to one-year terms as Directors of the Company the nominees listed in the Company's Proxy Statement dated April 20, 2012.
2. To ratify the Audit Committee's selection of Baker Newman & Noyes LLC as independent auditors of the Company for 2012.

At the Annual Meeting, there were present in person or by proxy 2,773,261 shares of the Company's common stock, representing 91.86% of the total outstanding eligible votes. The final voting results for each proposal are as follows:

1. To elect to one-year terms as Directors of the Company the nominees listed in the Company's Proxy Statement dated April 20, 2012.

                          For    Withheld Broker Non-Vote
Michael F. Brigham     1,314,150  17,472     1,441,639
Joseph H. Crabb        1,316,200  15,422     1,441,639
David S. Cunningham    1,313,139  18,483     1,441,639
William H. Maxwell     1,308,939  22,683     1,441,639
Linda Rhodes           1,313,762  17,860     1,441,639

2. To ratify the Audit Committee's selection of Baker Newman & Noyes LLC as independent registered public accounting firm of the Company for 2012.

For Against Abstain
2,758,740 6,514 8,007